278 related articles for article (PubMed ID: 8452812)
1. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer.
Azuma T; Motoyama N; Fields LE; Loh DY
Int Immunol; 1993 Feb; 5(2):121-30. PubMed ID: 8452812
[TBL] [Abstract][Full Text] [Related]
2. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
Hengstschläger M; Williams M; Maizels N
Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
4. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
5. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.
Betz AG; Milstein C; González-Fernández A; Pannell R; Larson T; Neuberger MS
Cell; 1994 Apr; 77(2):239-48. PubMed ID: 8168132
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism.
Hackett J; Stebbins C; Rogerson B; Davis MM; Storb U
J Exp Med; 1992 Jul; 176(1):225-31. PubMed ID: 1613457
[TBL] [Abstract][Full Text] [Related]
7. Somatic hypermutation in 5' flanking regions of heavy chain antibody variable regions.
Rothenfluh HS; Taylor L; Bothwell AL; Both GW; Steele EJ
Eur J Immunol; 1993 Sep; 23(9):2152-9. PubMed ID: 8370398
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
Tumas-Brundage KM; Vora KA; Manser T
Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
[TBL] [Abstract][Full Text] [Related]
9. Comparison of somatic mutation frequency among immunoglobulin genes.
Motoyama N; Miwa T; Suzuki Y; Okada H; Azuma T
J Exp Med; 1994 Feb; 179(2):395-403. PubMed ID: 8294856
[TBL] [Abstract][Full Text] [Related]
10. A 125 bp region of the Ig VH1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice.
Avitahl N; Calame K
Int Immunol; 1996 Sep; 8(9):1359-66. PubMed ID: 8921413
[TBL] [Abstract][Full Text] [Related]
11. Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells.
Sigurdardottir D; Sohn J; Kass J; Selsing E
J Immunol; 1995 Mar; 154(5):2217-25. PubMed ID: 7868895
[TBL] [Abstract][Full Text] [Related]
12. Activation of immunoglobulin control elements in transgenic mice.
Miller AE; Ennist DL; Ozato K; Westphal H
Immunogenetics; 1992; 35(1):24-32. PubMed ID: 1729170
[TBL] [Abstract][Full Text] [Related]
13. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.
Rogerson BJ
Mol Immunol; 1994 Feb; 31(2):83-98. PubMed ID: 8309480
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulatory sequences within the first intron of the chicken apolipoproteinAI (apoAI) gene.
Bhattacharyya N; Banerjee D
Gene; 1999 Jul; 234(2):371-80. PubMed ID: 10395911
[TBL] [Abstract][Full Text] [Related]
15. Analysis of promoter and enhancer cell type specificities and the regulation of immunoglobulin gene expression.
Doyen N; Leblond-Francillard M; Holm I; Dreyfus M; Rougeon F
Gene; 1986; 50(1-3):321-31. PubMed ID: 3495468
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
Sun Z; Kitchingman GR
Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
[TBL] [Abstract][Full Text] [Related]
17. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
Klotz EL; Storb U
J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
[TBL] [Abstract][Full Text] [Related]
18. Conserved patterns of somatic mutation and secondary VH gene rearrangement create aberrant Ig-encoding genes in Epstein-Barr virus-transformed and normal human B lymphocytes.
Brokaw JL; Wetzel SM; Pollok BA
Int Immunol; 1992 Feb; 4(2):197-206. PubMed ID: 1377945
[TBL] [Abstract][Full Text] [Related]
19. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
20. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
Elmaleh N; Matthias P; Schaffner W
Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
